Skip to main content
. Author manuscript; available in PMC: 2022 Dec 13.
Published in final edited form as: Genet Med. 2022 Sep 22;24(12):2526–2534. doi: 10.1016/j.gim.2022.08.023

Table 1.

Demographic characteristics for HINTS 5 cycle 4 respondents (N = 3767)

Characteristic n Wgt %a

Sex
 Male 1561 49
 Female 2206 51
Age, y
 18–34 500 26
 35–49 722 26
 50–64 1152 28
 65–74 862 12
 ≥75 531 8
Race/ethnicity
 Non-Hispanic White 2268 60
 Non-Hispanic Black 569 15
 Non-Hispanic Asian 174 5
 Non-Hispanic American Indian, Alaska Native, Pacific Islander 29 1
 Non-Hispanic multiracial 108 3
 Hispanic 619 16
Level of education
 High school or less 973 30
 Some college 2794 70
Employment statusb
 Employed 1852 59
 Retired 1165 19
 Disabled 201 5
 Other 298 12
 Not employed 130 4
Health insurance status
 Insured 3568 91
 Not insured 199 9
Incomec
 Less than $20,000 609 15
 $20,000 to $49,999 890 24
 $50,000 to $99,999 982 31
 $100,000 or higher 909 30
Marital status
 Married 2010 55
 Otherd 1104 14
 Never married 653 31
Personal history of cancer
 Yes 464 7
 No 3303 93
Type of cancer
 Breast cancer 105 19
 Prostate cancer 84 9
 Othere 275 72
Family history of cancerc
 Yes 2630 70
 No 720 22
 Not Sure 308 8

HINTS, Health Information National Trends Survey; Wgt, weighted.

a

These were calculated using jackknife replication.

b

Participants who reported of being employed full or part time were categorized as “employed.” Participants who were retired, disabled, students, homemakers, or other were categorized as “not employed.” n = 121 participants were missing responses for employment.

c

n = 377 participants were missing responses for income, and 109 were missing responses for family history of cancer.

d

The “other” category included participants who were widowed, divorced, or separated.

e

Participants belonging to the “other” cancer type category included those with bladder cancer, bone cancer, cervical cancer, colon cancer, endometrial cancer, head/neck cancer, Hodgkin’s lymphoma, renal cancer, leukemia, liver cancer, lung cancer, non-Hodgkin’s, oral cancer, ovarian cancer, pancreatic cancer, pharyngeal cancer, rectal cancer, melanoma, or another type of cancer.